drugset
drugset / Trial / NCT05155007

A Study in Healthy Adult Participants to Assess the Effects of Ciclosporin Administration on Rilematovir

NCT05155007 ↗

Phase 1 Completed 18 enrolled Janssen Research & Development, LLC
RandomizedCrossoverOpen-labelBasic science

Summary

The purpose of this study is to evaluate the pharmacokinetic (PK) of a single-dose of rilematovir co-administered with a single-dose of ciclosporin compared to a single-dose administration of rilematovir alone.

Timeline

Start
2021-12-10
Primary completion
2022-02-04
Completion
2022-02-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Cyclosporine Peptide — Oral
Subject Rilematovir Other / unclassified — Oral

Indications

No indication recorded.